• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[终末期肾衰竭患者不同类型左心室肥厚中的舒张功能障碍:长期促红细胞生成素治疗的影响]

[Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end-stage renal failure: impact of long-term erythropoietin therapy].

作者信息

Dzgoeva F U, Gatagonova T M, Kadzaeva Z K, Khamitsaeva O V, Kochisova Z Kh, Dzueva A T, Bazaeva B G, Bestaeva T L

出版信息

Ter Arkh. 2013;85(6):44-50.

PMID:23866598
Abstract

AIM

To study the specific features of diastolic dysfunction (DD) in different types of left ventricular (LV) hypertrophy (LVH) in patients with end-stage renal failure (ESRF) and to estimate the cardioprotective effect of erythropoietin.

SUBJECTS AND METHODS

107 patients (57 women and 50 men) aged 22 to 63 years with ESRF were examined. The follow-up was 18 months. LV ejection fraction, peak early diastolic filling rate, peak late diastolic filling rate, their ratio, LV isovolumic relaxation time, LV end-diastolic diameter, LV end-diastolic volume, LV end-diastolic diameter index (EDDI), LV posterior wall and ventricular septal thickness, and LV mass index were determined. J. Gottdiener's classification based on the calculation of EDDI and LV relative wall thickness was used to estimate LV geometry. Erythropoietin was given to patients with the baseline level of hemoglobin (Hb) < 110 g/l or hematocrit (Ht) < 33%; and iron (III) hydroxide sucrose complex was used to those with ferritin < 100 microg/l or transferrin saturation < 20%. The target level of blood pressure was 130/80 mm Hg; Hb was less than 110 g/l for women and 120 g/l for men; Ht, > 33%.

RESULTS

The patients with ESRF were found to have different types of DD and LVH, the severity of which correlated with the magnitude of renal anemia and arterial hypertension (AH). Adequate correction of anemia and AH promoted the transition of more to less severe DD and LVH and in a number of cases the recovery of LV structure and function.

CONCLUSION

ESRF is characterized by different types of DD, which are pathogenetically closely related to different types of LVH. Adequate correction of renal anemia and AH may cause a significant reduction and, in a number of cases, alleviate VLH, and normalize LV systolic and diastolic functional values.

摘要

目的

研究终末期肾衰竭(ESRF)患者不同类型左心室(LV)肥厚(LVH)中舒张功能障碍(DD)的具体特征,并评估促红细胞生成素的心脏保护作用。

对象与方法

对107例年龄在22至63岁的ESRF患者(57例女性和50例男性)进行检查。随访时间为18个月。测定左心室射血分数、舒张早期充盈峰值速率、舒张晚期充盈峰值速率、它们的比值、左心室等容舒张时间、左心室舒张末期直径、左心室舒张末期容积、左心室舒张末期直径指数(EDDI)、左心室后壁和室间隔厚度以及左心室质量指数。采用基于EDDI和左心室相对壁厚度计算的J.戈特迪纳分类法来评估左心室几何形状。血红蛋白(Hb)基线水平<110 g/l或血细胞比容(Ht)<33%的患者给予促红细胞生成素;铁蛋白<100 μg/l或转铁蛋白饱和度<20%的患者使用氢氧化铁(III)蔗糖复合物。血压目标水平为130/80 mmHg;女性Hb<110 g/l,男性Hb<120 g/l;Ht>33%。

结果

发现ESRF患者存在不同类型的DD和LVH,其严重程度与肾性贫血和动脉高血压(AH)的程度相关。贫血和AH的充分纠正促使更严重的DD和LVH向较轻的转变,并且在一些情况下左心室结构和功能得以恢复。

结论

ESRF的特征是不同类型的DD,其在发病机制上与不同类型的LVH密切相关。肾性贫血和AH的充分纠正可能导致显著减轻,并且在一些情况下缓解左心室肥厚,并使左心室收缩和舒张功能值正常化。

相似文献

1
[Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end-stage renal failure: impact of long-term erythropoietin therapy].[终末期肾衰竭患者不同类型左心室肥厚中的舒张功能障碍:长期促红细胞生成素治疗的影响]
Ter Arkh. 2013;85(6):44-50.
2
The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.维持性重组人促红细胞生成素治疗对动态血压记录的影响:传统、多普勒及组织多普勒超声心动图参数
Artif Organs. 2005 Dec;29(12):965-72. doi: 10.1111/j.1525-1594.2005.00166.x.
3
[Nitric oxide--a potential modulator of left ventricular diastolic function in hemodialysis patients treated with erythropoietin].[一氧化氮——接受促红细胞生成素治疗的血液透析患者左心室舒张功能的潜在调节因子]
Med Arh. 2004;58(2):109-12.
4
Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis.左西孟旦对主动脉瓣狭窄患者行主动脉瓣置换术后在维持前负荷和后负荷条件下左心室舒张及早期充盈的影响。
Circulation. 2008 Feb 26;117(8):1075-81. doi: 10.1161/CIRCULATIONAHA.107.722868. Epub 2008 Feb 11.
5
Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.促红细胞生成素对血液透析患者心血管预后参数的影响。
Kidney Int. 2004 Aug;66(2):832-40. doi: 10.1111/j.1523-1755.2004.00810.x.
6
Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.重组人促红细胞生成素治疗对透析患者左心室肥厚及心脏功能的影响。
Blood Purif. 1998;16(6):317-24. doi: 10.1159/000014351.
7
Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.生物类似药促红细胞生成素α治疗贫血血液透析患者24周后血红蛋白反应及其对左心室肥厚的影响
J Med Assoc Thai. 2007 Dec;90(12):2574-86.
8
[A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].硝苯地平缓释片治疗高血压性心脏病患者后左心室肥厚减轻及舒张功能改善
Cardiologia. 1993 Sep;38(9):585-91.
9
[Cardioprotective effect of erythropoietin preparations in patients with chronic renal failure].促红细胞生成素制剂对慢性肾衰竭患者的心脏保护作用
Ter Arkh. 2004;76(9):40-3.
10
Morphologic and functional changes of left ventricle in dialyzed patients after treatment with recombinant human erythropoietin (r-HuEPO).
Angiology. 2000 Feb;51(2):131-9. doi: 10.1177/000331970005100206.

引用本文的文献

1
High Prevalence of Cardiovascular Disease in End-Stage Kidney Disease Patients Ongoing Hemodialysis in Peru: Why Should We Care About It?秘鲁接受维持性血液透析的终末期肾病患者心血管疾病的高患病率:我们为何要关注它?
Int J Nephrol. 2015;2015:568702. doi: 10.1155/2015/568702. Epub 2015 Jul 29.